Selected Podcast

EP 1022B - Heart Attack Damage Reduced by Shielded Stem Cells

Bioengineers and surgeons from Rice University and Baylor College of Medicine (BCM) have shown that shielding stem cells with a novel biomaterial improve the cells' ability to heal heart injuries caused by heart attacks.

In a study using rodents, a team led by Rice's Dr. Omid Veiseh and Baylor's Ravi Ghanta showed it could make capsules of wound-healing mesenchymal stem cells (MSCs) and implant them next to wounded hearts using minimally invasive techniques. Within four weeks, heart-healing was 2.5 times greater in animals treated with shielded stem cells than those treated with nonshielded stem cells, the researchers found.

Someone has a heart attack every 40 seconds in the United States. In each case, an artery that supplies blood to the heart becomes blocked and heart muscle tissue dies due to lack of blood. Hearts damaged by heart attacks pump less efficiently, and scar tissue from heart attack wounds can further reduce heart function.

Dr. Omid Veiseh is on the show today to tell us more about these findings. 

Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor


Persona logo


 

Bonus
How Your Diet Affects Your Risk for Cancer



EP 1022B - Heart Attack Damage Reduced by Shielded Stem Cells
Featuring:
Dr. Omid Veiseh
Dr. Omid Veiseh is an Assistant Professor and CPRIT Scholar in Cancer Research in the Department of Bioengineering at Rice University. He received a dual Ph.D. in Materials Science & Engineering and Nanotechnology from the University of Washington. Dr. Veiseh completed his postdoctoral research with Prof. Robert Langer and Prof. Daniel Anderson at MIT and Harvard Medical School. Over the course of his career, he has authored, or co-authored more than 50 peer-reviewed publications including those in Nature, Nature Biotechnology, Nature Materials, Nature Medicine, and is an inventor on 20 pending or awarded patents, many of which have been licensed for commercialization by 3 separate biotechnology companies. Throughout his career, he has received numerous awards and fellowships including a $2 million CPRIT Scholar In Cancer Research Award from the state of Texas and was recently named one of MedTech Boston’s 40 Under 40 Healthcare Innovators for 2017.